Compile Data Set for Download or QSAR
maximum 50k data
Report error Found 349 Enz. Inhib. hit(s) with all data for entry = 2041
TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351110(US9796700, Compound I-205)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351111(US9796700, Compound I-206)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351113(US9796700, Compound I-208)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351116(US9796700, Compound I-211)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351117(US9796700, Compound I-212)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351119(US9796700, Compound I-214)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351126(US9796700, Compound I-221)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351133(US9796700, Compound I-228)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351134(US9796700, Compound I-229)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351142(US9796700, Compound I-237)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351145(US9796700, Compound I-240)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351146(US9796700, Compound I-241)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351147(US9796700, Compound I-242)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351148(US9796700, Compound I-243)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351153(US9796700, Compound I-248)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351157(US9796700, Compound I-258)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351184(US9796700, Compound I-281)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351186(US9796700, Compound I-283)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351187(US9796700, Compound I-284)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351189(US9796700, Compound I-286)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351192(US9796700, Compound I-289)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351194(US9796700, Compound I-291)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351195(US9796700, Compound I-292)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351199(US9796700, Compound I-296)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351200(US9796700, Compound I-297)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351203(US9796700, Compound I-319)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351205(US9796700, Compound I-314)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351208(US9796700, Compound I-317)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351209(US9796700, Compound I-318)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351211(US9796700, Compound I-322)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351213(US9796700, Compound I-324)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351217(US9796700, Compound I-328)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351223(US9796700, Compound I-334)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351233(US9796700, Compound I-344)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351250(US9796700, Compound I-361)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM351253(US9796700, Compound I-364)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350908(US9796700, Compound I-2)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350911(US9796700, Compound I-5)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350913(US9796700, Compound I-7)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350915(US9796700, Compound I-9)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350916(US9796700, Compound I-10)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350919(US9796700, Compound I-13)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350921(US9796700, Compound I-15)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350923(US9796700, Compound I-17)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350924(US9796700, Compound I-18)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350925(US9796700, Compound I-19)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350927(US9796700, Compound I-20)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350929(US9796700, Compound I-307)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350932(US9796700, Compound I-23)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


TargetMitogen-activated protein kinase 3(Human)
Celgene Car

US Patent
LigandPNGBDBM350946(US9796700, Compound I-36)
Affinity DataIC50: <100nMAssay Description:The protocol below describes continuous-read kinase assays to measure potency of compounds against activated ERK1 enzyme. The mechanics of the assay ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent


Displayed 1 to 50 (of 349 total ) | Next | Last >>
Jump to: